COVID-19 and kidney disease: insights from epidemiology to inform clinical practice

V Mahalingasivam, G Su, M Iwagami… - Nature Reviews …, 2022 - nature.com
Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

[HTML][HTML] The global impact of COVID-19 on solid organ transplantation: two years into a pandemic

A Nimmo, D Gardiner, I Ushiro-Lumb, R Ravanan… - …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients

D Bertrand, M Hamzaoui, V Lemée… - Journal of the …, 2021 - journals.lww.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study

E Goffin, A Candellier, P Vart, M Noordzij… - Nephrology Dialysis …, 2021 - academic.oup.com
Abstract Background Coronavirus disease 2019 (COVID-19) has exposed haemodialysis
(HD) patients and kidney transplant (KT) recipients to an unprecedented life-threatening …

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

M Espi, X Charmetant, T Barba, C Mathieu… - Kidney international, 2022 - Elsevier
The level of protection achieved by the standard two doses of COVID-19 mRNA vaccines in
patients receiving maintenance hemodialysis (MHD) remains unclear. To study this we used …

High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients

N Longlune, MB Nogier, M Miedougé… - Nephrology Dialysis …, 2021 - academic.oup.com
Background Patients with chronic kidney disease, dialysis patients and kidney transplant
patients are at high risk of developing severe coronavirus disease 2019 (COVID-19). Data …

[HTML][HTML] Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era

AB Massie, WA Werbel, RK Avery, TPY Chiang… - American Journal of …, 2022 - Elsevier
Estimating the total coronavirus disease 2019 (COVID-19) mortality burden of solid organ
transplant recipients (SOTRs), both directly through COVID-19 infection and indirectly …

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

X Charmetant, M Espi, I Benotmane… - Science translational …, 2022 - science.org
Transplant recipients, who receive therapeutic immunosuppression to prevent graft
rejection, are characterized by high coronavirus disease 2019 (COVID-19)–related mortality …

At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis

C Combe, AH Kirsch, G Alfano… - Nephrology Dialysis …, 2021 - academic.oup.com
Database (ERACODA) Working Group has recently highlighted the extremely high burden of
coronavirus disease 2019 (COVID-19) infection in chronic kidney disease (CKD) patients …

The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient–One year into the pandemic

P Khairallah, N Aggarwal, AA Awan… - Transplant …, 2021 - Wiley Online Library
The COVID‐19 pandemic has significantly changed the landscape of kidney transplantation
in the United States and worldwide. In addition to adversely impacting allograft and patient …